|
UR8000 Coagulation Analyzer – High-Throughput Automated Hemostasis Testing System
China’s diagnostics manufacturing ecosystem is now producing instruments that rival global leaders in throughput, pushing the cost of high-volume coagulation testing downward and reshaping lab procurement priorities.
The UR8000 is a fully automated hemostasis analyzer that processes up to 900 tests per hour across 40 detection channels, handling PT, APTT, FIB, TT, and D-Dimer simultaneously. It supports coagulation, immunoturbidimetric, and chromogenic assays on a single platform, eliminating the need for separate workstations in medium-to-large clinical labs.
Operationally, the system removes friction at multiple points: closed-tube sampling with cap-piercing reduces biohazard exposure, while automated detection of hemolysis, icterus, and lipemia flags compromised samples before they waste reagents or generate invalid results. Its compatibility with laboratory automation systems allows it to integrate into existing track-based workflows without manual buffering.
For hospital networks or independent diagnostic chains running thousands of coagulation panels daily, the UR8000’s throughput and assay flexibility translate directly into reduced turnaround times and lower per-test labor costs. The large-capacity reagent and cuvette systems further minimize operator intervention during peak loads.
The instrument’s technical profile reflects a broader industrial shift: Chinese manufacturers are now engineering for Tier-1 performance benchmarks while pricing competitively for domestic and emerging-market procurement. This positions the UR8000 as a viable alternative to legacy platforms from established diagnostics incumbents.
As hemostasis testing volumes grow with aging populations and expanding surgical capacity, automation becomes a constraint, not a luxury. The UR8000 is a response to that bottleneck—a piece of infrastructure designed to absorb scale without sacrificing precision.
Why it matters:
For lab managers and procurement teams, the UR8000 represents a step change in cost-per-test at high volume. For supply chain watchers, it signals that Chinese diagnostic OEMs have closed the gap in automated coagulation platforms, increasing buyer options and competitive pressure.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.